If you read the book you'll notice that I-messages are a rough approximation of the tools. Sometimes I think this summary does more harm than good by presenting it without the richness of the book
I think this summary offers template solutions. They are an approximation of the insights of the book. The book is more about relating a human experience to a conversation,
I'm sad my comment came off as snooty. Its not meant to be. I'm not the smartest guy in the room by a long shot. I've just seen things that people in smaller ponds haven't. ICs at my last company in the bay make more than very senior people here. All of the cost of living calcs are essentially BS unless you have kids
I don't have prestige, I'm not a 10x coder, I'm not special.
I'm sure you have reasons for what you do. I don't like SF or the bay and I'm happy you have a great family.
You can also become very 'senior' in level without exposure or experience that would be comparable to somebody in SF. Its a bummer when you live there, but the whole city lives and breathes tech. You can't get that elsewhere.
Having just moved from SF to a smaller market with a 'lower cost of living' I can tell you DO NOT DO IT
The value you lose from your current and future network alone is so devastating that any NerdWallet estimate of your costs is total BS. Lookup how much networks are worth to lifetime earnings
Now your job sucks? Good luck getting a new one you like. Either move back or find something that 'works'
Lastly, your coworkers will be from a smaller pond and instead of learning with the most experienced, you'll atropying your progress as you argue for basic things with people who've never worked in a big pond.
There's a reason people go to hollywood for movies and SF for tech. A bunch of them actually.
I could be lead to that conclusion, but I see this another way. Running the business of a multinational pharma company doesn't qualify you to judge primary literature in microbiology, methods, or data science of the results. It also doesn't help you differentiate claims from hot air in this emerging space. Considering the maturity of this field I think these are the skills required for due diligence. I think a pharma CEO as well as you and I are at the mercy of pop-sci reporting.
It is interesting. Theranos appointed high-profile people who were incapable of doing due diligence on their product. I wonder if this is another one of those.